Additional file 1: Table S1. Age related treatment response of the three groups:Participants in the three treatment arms were grouped into > 40 years old or ≤ 40 years old subgroup. Those main outcomes were compared between participants of each subgroup within and between/among these three treatment groups, including ΔUACR, ΔSU, ΔpH, pH ≥ 6.2 at week12 and SU < 360 μmol/L at week 12 in vs in three treatment groups, and no significant difference was observed between subgroups. Table S2. Gout flares in the intent-to-treat set. Fig. S1. DECT urate volumes. Significant differences (p < 0.05) were observed in Sodium bicarbonate, Citrate mixture and TaCCi mixture group between baseline and week 12, while no significant difference was observed bet...
Figure S1. Box plot of the initial volume of monosodium urate deposits in the feet measured with dua...
Despite the availability of effective urate-lowering therapy (ULT) and anti-inflammatory drugs for t...
Contains fulltext : 171906.pdf (publisher's version ) (Open Access)INTRODUCTION: G...
Introduction: Gout is a painful form of inflammatory arthritis associated with several comorbidities...
Table S1. Type and dosage of diuretics. Table S2. Comparison of maximum dose of urate-lowering drugs...
Additional file 1: Table S1. STROBE Checklist for Cross-sectional Studies. Table S2. Associations of...
Table S1. Renal-related and kidney stone TEAEs. Table S2. TEAEs with >â5% of patients in either to...
Table S1. Prevalence of gout by age group and gender from the South Australian 2015 Health Omnibus S...
Association between serum urate levels (ÎźmolL â1) and tomato consumption (serves/week) adjusted f...
Background: Gout is a frequently occurring, complex rheumatologic form of inflammatory arthritis cau...
Table S2. Demographic characteristics and prevalence (95% CIs) of comorbidities for gout cases and c...
Association between serum urate levels (ÎźmolL â1) and consumption of five established urate influ...
The methodological quality of cross-sectional studies in accordance with the Newcastle-Ottawa Scale ...
The Raw 264.7 cells were treated with or without LPS (1 μg/ml) for 6 h and then stimulated with MSU ...
ARIC, CHS and FHS food frequency questionnaire answer categories and conversion to serves/week. (DOC...
Figure S1. Box plot of the initial volume of monosodium urate deposits in the feet measured with dua...
Despite the availability of effective urate-lowering therapy (ULT) and anti-inflammatory drugs for t...
Contains fulltext : 171906.pdf (publisher's version ) (Open Access)INTRODUCTION: G...
Introduction: Gout is a painful form of inflammatory arthritis associated with several comorbidities...
Table S1. Type and dosage of diuretics. Table S2. Comparison of maximum dose of urate-lowering drugs...
Additional file 1: Table S1. STROBE Checklist for Cross-sectional Studies. Table S2. Associations of...
Table S1. Renal-related and kidney stone TEAEs. Table S2. TEAEs with >â5% of patients in either to...
Table S1. Prevalence of gout by age group and gender from the South Australian 2015 Health Omnibus S...
Association between serum urate levels (ÎźmolL â1) and tomato consumption (serves/week) adjusted f...
Background: Gout is a frequently occurring, complex rheumatologic form of inflammatory arthritis cau...
Table S2. Demographic characteristics and prevalence (95% CIs) of comorbidities for gout cases and c...
Association between serum urate levels (ÎźmolL â1) and consumption of five established urate influ...
The methodological quality of cross-sectional studies in accordance with the Newcastle-Ottawa Scale ...
The Raw 264.7 cells were treated with or without LPS (1 μg/ml) for 6 h and then stimulated with MSU ...
ARIC, CHS and FHS food frequency questionnaire answer categories and conversion to serves/week. (DOC...
Figure S1. Box plot of the initial volume of monosodium urate deposits in the feet measured with dua...
Despite the availability of effective urate-lowering therapy (ULT) and anti-inflammatory drugs for t...
Contains fulltext : 171906.pdf (publisher's version ) (Open Access)INTRODUCTION: G...